Tag: $Nektar Therapeutics

Nektar Therapeutics stock soars after atopic dermatitis drug hits key targets

Nektar Therapeutics (NASDAQ:NKTR) stock surged 140% after the company announced its experimental drug rezpegaldesleukin met primary and key secondary endpoints in a Phase 2b study for moderate-to-severe atopic dermatitis.